Effect of epinephrine on platelet-activating factor-stimulated human vascular smooth muscle cells

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 5, 2012, Pages 1329-1333

  Vadas, Peter ^a   Perelman, Boris ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

anaphylaxis; Epinephrine; human vascular smooth muscle cells; platelet activating factor; platelet activating factor receptor

Indexed keywords

8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; ADRENALIN; FORSKOLIN; PROPRANOLOL; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANAPHYLAXIS; AORTA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; VASCULAR SMOOTH MUSCLE;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANAPHYLAXIS; AORTA; CELLS, CULTURED; DINOPROSTONE; EPINEPHRINE; HUMANS; MYOCYTES, SMOOTH MUSCLE; PLATELET ACTIVATING FACTOR;

EID: 84860450557     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.02.027     Document Type: Article

References (49)

1. H.A. Sampson, A. Muñoz-Furlong, S.A. Bock, C. Schmitt, R. Bass, and B.A. Chowdhury Symposium on the Definition and Management of Anaphylaxis: summary report J Allergy Clin Immunol 115 2005 584 591
2. H.A. Sampson, A. Muñoz-Furlong, R.L. Campbell, N.F. Adkinson Jr., S.A. Bock, and A. Branum Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium J Allergy Clin Immunol 117 2006 391 397
3. F.E. Simons Anaphylaxis J Allergy Clin Immunol 121 suppl 2008 S402 S407
4. P. Lieberman Biphasic anaphylactic reactions Ann Allergy Asthma Immunol 95 2005 217 226
5. R.S. Pumphrey Lessons for management of anaphylaxis from a study of fatal reactions Clin Exp Allergy 30 2000 1144 1150
6. H. Sampson, L. Mendelson, and J. Rosen Fatal and near-fatal anaphylactic reactions to food in children and adolescents N Engl J Med 327 1992 380 384
7. R.S. Pumphrey, and M.H. Gowland Further fatal allergic reactions to food in the United Kingdom 1999-2006 J Allergy Clin Immunol 119 2007 1018 1019
8. D.M. Stafforini, T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes Crit Rev Clin Lab Sci 40 2003 643 672
9. Z. Honda, M. Nakamura, I. Miki, M. Minami, T. Watanabe, and Y. Seyama Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung Nature 349 1991 342 346
10. T. Izumi, and T. Shimizu Platelet-activating factor receptor: gene expression and signal transduction Biochim Biophys Acta 1259 1995 317 333
11. V.M. Doyle, J.A. Creba, and U.T. Ruegg Platelet activating factor mobilizes intracellular calcium in vascular smooth muscle cells FEBS Lett 197 1986 13 16
12. H. Kawaguchi, and H. Yasuda Platelet activating factor stimulates prostaglandin synthesis in cultured cells Hypertension 8 1986 192 197
13. F. Gaumond, D. Fortin, J. Stankova, and M. Rola-Pleszczynski Differential signaling pathways in platelet activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells J Cardiovascular Pharmacol 30 1997 169 175
14. A. Nakao, T. Watanabe, H. Bitoch, H. Imaki, T. Suzuki, and K. Asano cAMP mediates homologous downregulation of PAF receptor mRNA expression in mesangial cells Am J Physiol 273 1997 F445 F450
15. W. Chao, H. Liu, W. Zhou, D. Hanahan, and M. Olson Regulation of platelet activating factor receptor and platelet activating factor receptor-mediated biological responses by cAMP in rat Kupffer cells J Biol Chem 265 1990 17576 17583
16. T. Ashikaga, Y. Kishi, and F. Numano Comparison of the effects of vasoactive agents on adenylate cyclase activity in endothelial and smooth muscle cells from the same specimen of fetal bovine aorta Clin Exp Pharmacol Physiol 23 1996 36 42
17. G. Montrucchio, G. Alloatti, and G. Camussi Role of platelet activating factor in cardiovascular pathophysiology Physiol Rev 80 2000 1669 1699
18. S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre Platelet-activating factor J Biol Chem 265 1990 17381 17384
19. F.D. Finkelman, M.E. Rothenberg, E.B. Brandt, S.C. Morris, and R.T. Strait Molecular mechanisms of anaphylaxis: lessons from studies with murine models J Allergy Clin Immunol 115 2005 449 457
20. P. Vadas, M. Gold, B. Perelman, G.M. Liss, G. lack, and T. Blyth Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis N Engl J Med 358 2008 28 35
21. S. Ishii, T. Kuwaki, T. Nagase, K. Maki, F. Tashiro, and S. Sunaga Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor J Exp Med 187 1998 1779 1788
22. G. Marone, M. Bova, A. Detoraki, A.M. Onorati, F.W. Rossi, and G. Spadaro The human heart as a shock organ in anaphylaxis Novartis Found Symp 257 2004 133 149
23. L.B. Schwartz Effector cells of anaphylaxis: mast cells and basophils Novartis Found Symp 257 2004 65 74
24. G. Marone, M. Triggiani, and A. de Paulis Mast cells and basophils: friends as well as foes in bronchial asthma? Trends Immunol 26 2005 25 31
25. S.H. Sicherer, and F.E.R. Simons Self-injectable epinephrine for first aid management of anaphylaxis Pediatrics 119 2007 638 646
26. S. Bock, A. Munoz-Furlong, and H. Sampson Fatalities due to anaphylactic reactions to foods J Allergy Clin Immunol 107 2001 191 193
27. A.P. McLean-Tooke, C.A. Bethune, A.C. Fay, and G.P. Spickett Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 327 2003 1332 1335
28. T.A. Imaizumi, D.M. Stafforini, Y. Yamada, T.M. McIntyre, S.M. Prescott, and G.A. Zimmerman Platelet-activating factor: a mediator for clinicians J Intern Med 238 1995 5 20
29. J.M. Heery, M. Kozak, D.M. Stafforini, D.A. Jones, G.A. Zimmerman, and T.M. McIntyre Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells J Clin Invest 96 1995 2322 2330
30. S.B. Hwang Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms J Lipid Mediat 2 1990 123 158
31. W. Chao, and M.S. Olson Platelet-activating factor: receptors and signal transduction Biochem J 292 1993 617 629
32. S.D. Shukla Platelet-activating factor receptor and signal transduction mechanisms Lipids 26 1991 1028 1033
33. M.D. Houslay, D. Bojanic, and A. Wilson Platelet-activating factor and U44069 stimulate GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory Biochem J 234 1986 737 740
34. A.S. Weyrich, T.M. McIntyre, R.P. McEver, S.M. Prescott, and G.A. Zimmerman Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappaB translocation J Clin Invest 95 1995 2297 2303
35. F.H. Valone, E. Coles, V.R. Reinhold, and E.J. Goetzl Specific binding of phospholipids platelet-activating factor by human platelets J Immunol 129 1982 1637 1641
36. N.G. Bazan, S.P. Squinto, P. Braquet, T. Panetta, and V.L. Marcheselli Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system Lipids 26 1991 1236 1242
37. M. Thivierge, J.L. Parent, J. Stankova, and M. Rola-Pleszczynski Modulation of human platelet-activating factor receptor gene expression by protein kinase C activation J Immunol 157 1996 4681 4687
38. W. Chao, H.L. Liu, W.G. Zhou, D.J. Hanahan, and M.S. Olson Regulation of platelet-activating factor receptor and platelet-activating factor receptor mediated biological responses by cAMP in rat Kupffer cells J Biol Chem 265 1990 17576 17583
39. M. Thivierge, N. Alami, E. Müller, A.J. de Brum-Fernandes, and M. Rola-Pleszczynski Transcriptional modulation of platelet-activating factor receptor gene expression by cAMP J Biol Chem 268 1993 17457 17462
40. N. Ueno, Y. Taketomi, K. Yamamoto, T. Hirabayashi, D. Kamei, and Y. Kita Analysis of two major intracellular phospholipases A(2) (PLA(2)) in mast cells reveals crucial contribution of cytosolic PLA(2)α, not Ca(2+)-independent PLA(2)β, to lipid mobilization in proximal mast cells and distal fibroblasts J Biol Chem 286 2011 37249 37263
41. M. Harczy, J. Maclouf, P. Pradelles, P. Braquet, P. Borgeat, and P. Sirois Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung Pharmacol Res Commun 18 1986 111 117
42. S. Jancar, P. Braquet, and P. Sirois Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions Braz J Med Biol Res 20 1987 487 494
43. P. Sirois, M. Harczy, P. Braquet, P. Borgeat, J. Maclouf, and P. Pradelles Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF Adv Prostaglandin Thromboxane Leukot Res 17 1987 1033 1037
44. A. Bellou, H. Lambert, P. Gillois, C. Montemont, P. Gerard, and E. Vauthier Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown Norway rats anaphylactic shock Shock 19 2003 71 78
45. K.J. Simons, and F.E.R. Simons Epinephrine and its use in anaphylaxis: current issues Curr Opin Allergy Clin Immunol 10 2010 354 361
46. S.A. Bock, A. Munoz-Furlong, and H.A. Sampson Further fatalities caused by anaphylactic reactions to food, 2001-2006 J Allergy Clin Immunol 119 2007 1016 1018
47. P.A. Greenberger, B.D. Rotskoff, and B. Lifschultz Fatal anaphylaxis: postmortem findings and associated comorbid diseases Ann Allergy Asthma Immunol 98 2007 252 257
48. A.P.C. McLean-Tooke, C.A. Bethune, A.C. Fay, and G.P. Spickett Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 327 2003 1332 1335
49. S.F. Kemp, R.F. Lockey, and F.E.R. Simons Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization Allergy 63 2008 1061 1070